Effects of Sodium-Glucose Co-Transporter-2 Inhibition on Pulmonary Arterial Stiffness and Right Ventricular Function in Heart Failure with Reduced Ejection Fraction

Background and Objectives: In addition to left ventricular (LV) functions, right ventricular (RV) functions and pulmonary arterial stiffness (PAS) may be adversely affected in patients with heart failure with reduced ejection fraction (HFrEF). Sodium-glucose co-transporter-2 (SGLT2) inhibitor therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Çamcı, Sencer, Yılmaz, Emre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415977/
https://www.ncbi.nlm.nih.gov/pubmed/36013595
http://dx.doi.org/10.3390/medicina58081128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9415977/
https://www.ncbi.nlm.nih.gov/pubmed/36013595
http://dx.doi.org/10.3390/medicina58081128

Ejemplares similares